All articles by Alexandra Carrera

  1. Ramucirumab misses endpoint for breast cancer but proves effective for gastric cancer

    Eli Lilly and Company has announced that its drug ramucirumab has not succeeded in improving the survival rate of metastatic…
    Read More…

    26 Sep
  2. Bayer’s hypertension drug granted designation by FDA

    Bayer HealthCare has been given two separate orphan drug designations from the US Food and Drug Administration’s (FDA) Office of…
    Read More…

    25 Sep
  3. GSK hepatitus C treatment granted additional indication in Europe

    GlaxoSmithKline’s (GSK) hepatitis C drug Revolade (eltrombopag) has been given marketing authorisation for an additional indication by the European Commission….
    Read More…

    23 Sep
  4. UCSD researchers develop new antibiotics detection technique

    Biologists at the University of California, San Diego (UC San Diego) have developed a new procedure that can identify and…
    Read More…

    22 Sep
  5. GSK signs deal with BARDA for anti-anthrax medication

    GlaxoSmithKline (GSK) has signed a four-year contract with the Biomedical Advanced Research and Development Authority (BARDA), a division of the…
    Read More…

    19 Sep
  6. European Commission gives marketing approval for prostate cancer drug

    US-based biotechnology company Dendreon Corporation has received marketing authorisation from the European Commission (EC) for its prostate cancer treatment, Provenge…
    Read More…

    18 Sep
  7. Multiple sclerosis treatment endorsed by the EMA

    Multiple sclerosis (MS) drug alemtuzumab, marketed under the brand name Lemtrada, has been approved by the European Medicines Agency (EMA)….
    Read More…

    17 Sep
  8. Genzyme’s multiple sclerosis treatment approved by European Commission

    Sanofi and its subsidiary Genzyme have been given marketing approval by the European Commission for Lemtrada (alemtuzumab), a treatment for…
    Read More…

    16 Sep
  9. Columbia Laboratories acquires UK pharma developer

    Columbia Laboratories has purchased UK-based Molecular Profiles, a pharmaceutical formula developer and manufacturer, for an estimated $25m. The deal will…
    Read More…

    15 Sep
  10. Roche partners with Inovio Pharma on prostate cancer and hepatitis B therapies

    Roche has reached a licence agreement with US-based Inovio Pharmaceuticals to develop and promote Inovio’s multi-antigen DNA immunotherapies for the…
    Read More…

    11 Sep
Close
Close
Close

Go Top